Press Releases about Lexaria Bioscience Corp
Lexaria's Human Clinical Hypertension Study a Success
October 27, 2022
Via ACCESSWIRE
Lexaria Bioscience Corp. (NASDAQ: LEXX), Growing its Market Share, One Patent at a Time
September 16, 2022
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|